Klebsiella infection/Pseudomonas infection conjugate vaccine (GSK/Astellas)

N/A

Report date: 2025/01/26 19:17:38

Base Information

Drug NameKlebsiella infection/Pseudomonas infection conjugate vaccine (GSK/Astellas)
Drug Alias NameKlebsiella infection/Pseudomonas infection conjugate vaccine (Affinivax/Astellas)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPseudomonas InfectionsKlebsiella Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffinivax Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcAstellas Pharma Inc
Inactive CompaniesAffinivax Inc
Active IndicationsPseudomonas InfectionsKlebsiella Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A